Reddit Shares Slide Nearly 6 After Meta Launches Standalone Facebook Groups App Forum Vanguard Corporate Releases Economic Outlook for Canada A ForwardLooking Assessment Spotify Soars After AI Music Deal With Universal Music Group and LongTerm Guidance US Defense Policy Shifts Raise Questions for NATO Allies and Defense Sector Gold Surpasses 4500 Mark Select Miners Below 45 Attract Market Attention Chhatrapati Sambhajinagar Residence of Cockroach Janata Party Founder Dipke Granted Police Protection Amid Growing Online Movement NexGel Inc NXGL Q1 2026 Earnings EPS Misses Estimates as Losses Widen Washington Trust Bancorp Inc WASH Q1 2026 Earnings EPS Misses Estimates as Net Interest Margin Faces Pressure WPM Q1 2026 Earnings EPS Surpasses Estimates by 23 GTIM Q1 2026 Earnings Small Profit Reported Stock Gains SHIM Q1 2026 Earnings EPS Misses Estimates as Stock Declines 8 BDCI Q1 2026 Earnings Positive EPS of 005 Reported Despite Absence of Revenue Details BNS Stock Edges Higher as Support Holds Bank Nova Scotia Preferred Shares in Focus Li Bang International Slips Fractionally Support at 086 in Focus Ethan Allen Interiors ETD Holds Steady Near Key Support as Consolidation Continues Betterware de Mexico BWMX Surges 33 as Shares Approach Key Resistance Level Central Garden Pet CENTA Holds Near Support Amid Modest Decline Market Movers SpaceX IPO Speculation Nvidia Earnings and Bezos on AI Bubble ARE Q1 2026 Earnings Massive EPS Surprise Highlights Operational Strength Coastal Financial Corporation CCB Gains Ground Testing Key Resistance Levels HURN Q1 2026 Earnings Earnings Per Share Surpasses Consensus by 58 IO Biotech Q3 2025 Earnings EPS Beat of 6067 Surprise but No Revenue from PreCommercial Pipeline DPRO Q1 2026 Earnings EPS Misses Estimates Narrowly Stock Surges 1387 BrightView Holdings Inc Q1 2026 Earnings EPS Falls Short Amid Challenging Season GEL Q1 2026 Earnings Significant EPS Miss Amid Challenging Conditions CLX Q1 2026 Earnings EPS Beats Estimates Stock Rises on Solid Performance CLDX Q1 2026 Earnings Slight EPS Miss as DevelopmentStage Biotech Continues NoRevenue Phase